Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
289 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 269 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2017-07-06 | 2017-08-04 | 14864 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-02-09 | 2018-03-05 | 39185 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-04-10 | 2019-06-10 | 45370 |
| MYOZYME | 50MG | POWDER FOR SOLUTION | Resolved | 2022-11-30 | 2022-12-07 | 176406 |
| NALCROM | 100MG | CAPSULE | Resolved | 2019-04-03 | 2019-06-26 | 80347 |
| NALCROM | 100MG | CAPSULE | Resolved | 2019-08-05 | 2019-08-24 | 90722 |
| NALCROM | 100MG | CAPSULE | Resolved | 2020-10-15 | 2020-11-25 | 126537 |
| NALCROM | 100MG | CAPSULE | Resolved | 2021-03-02 | 2021-05-22 | 134957 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-03-22 | 2022-03-28 | 157078 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-04-14 | 2022-05-04 | 158887 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-06-20 | 2022-09-24 | 163129 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-10-13 | 2023-07-01 | 171702 |
| NALCROM | 100MG | CAPSULE | Resolved | 2024-02-22 | 2024-10-07 | 220296 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2018-01-10 | 2018-02-19 | 35649 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2020-04-07 | 2020-04-15 | 111387 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2022-12-07 | 2023-02-09 | 177219 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2023-03-09 | 2024-05-03 | 186615 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2023-03-09 | 2024-06-15 | 186618 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Resolved | 2018-03-01 | 2018-05-08 | 41428 |
| PEDIAPRED | 5MG | SOLUTION | Resolved | 2017-11-01 | 2017-12-01 | 27673 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| FLAGYL | 10% | CREAM | Discontinued | 2024-03-28 | 2024-11-20 | 223877 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| MOZOBIL | 20MG | SOLUTION | To be discontinued | 2025-03-31 | 2025-03-31 | 253686 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
| NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |